Lupin has launched its generic of Tamiflu (oseltamivir) capsules. The drug is indicated to treat acute, uncomplicated influenza A and B in patients 2 weeks of age and older who’ve shown symptoms for no more than 48 hours. It also is indicated to prevent the flu in patients age 1 year and older.

Lupin’s generic will be available in 30-, 45- and 75-mg (base) dosage strengths. The product had U.S. sales of roughly $518 million for the 12 months ended December 2017, according to IQVIA data.